- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Topical TIMOLOL side effects(patient's awareness, prevention) , prescription, and pretreatment assessment. | ||
| Medical Journal of Tikrit | ||
| Article 1, Volume 2, Issue 162, 2016, Pages 150-156 | ||
| Author | ||
| Usama Jihad Abdul Qader | ||
| Abstract | ||
| The aim of this study was to estimate topical TIMOLOL side effects(patient's awareness, prevention) , prescription, and pretreatment assessment. In this study we interviewed five hundred (500) patients with open angle glaucoma, who attended the ophthalmology department -in Tikrit Teaching Hospital- for checking, at the period [June 2008- April 2009]. Direct interview questions were used to assess patients knowledge about (TIMOLOL) side effects and whether they received enough medical advices by their ophthalmologists or not. Also we determined the degree of cooperation between ophthalmologists and medical physicians regarding pretreatment assessment. Also we tried to answer an important question, who prescribed antiglaucoma drug (TIMOLOL)?.The results showed that 97% of interviewed patients didn’t have complete informations about (TIMOLOL) side effects, while only 3% have these informations. also 90% of patients didn’t know how they prevent systemic complications, by reducing systemic absorption. Only 83% of estimated patients received their treatment from senior ophthalmologists, 10% from permanent ophthalmologist, and 7% from general practitioner (GP). Weak cooperation between the ophthalmologists and medical physicians were detected, where only 5% of patients sent for medical consultation before starting the treatment. - Most of included patients with glaucoma didn’t have enough awareness of systemic side effects of topical (TIMOLOL), which may affect their general health. The perfect way to reduce the risk of systemic absorption of topical (TIMOLOL) not explained well for most of patients. Critical fact was discovered, topical (TIMOLOL) was prescribed for about 17% of patients by non-specialized ophthalmologists. Weak cooperation between the ophthalmologist and medical physicians have been detected (95% of patients didn’t receive medical consultation before starting TIMOLOL therapy) | ||
| Keywords | ||
| Scientific research speaks to the patient | ||
|
Statistics Article View: 58 PDF Download: 13 |
||